WASHINGTON,
D.C. — A number of advocacy
organizations are calling on the Filipino
American community to support a global effort to save Filipino children from
pneumonia, the leading cause of child mortality in the Philippines.
According
to the World Health Organization (WHO), the Philippines is one of 15 countries
that together account for 75 percent of childhood pneumonia cases worldwide. In
children aged under five years, pneumonia is the leading cause of mortality.
The
National Federation of Filipino American Associations (NaFFAA) is supporting
the petition drive spearheaded by NextDayBetter and Doctors Without Borders
that is directed at two pharmaceutical companies – Pfizer and GlaxoSmithKline (GSK) – the only
two producers of the life-saving pneumonia vaccine.
“We need
Pfizer and GSK to lower the pneumonia vaccine price in the Philippines, from
$45 to $5 per child,” says Ryan Letada of NextDayBetter, a storytelling
platform for creative diaspora communities, which uses digital media and global
speaker events to generate action and make an impact. “Many lives have been saved
by this vaccine, but pneumonia still kills nearly 1 million children every
year. The problem is urgent.”
NaFFAA’s
Director of Health, Dr. Rommel Rivera of Philadelphia, Pennsylvania, says the
situation is alarming and affirms NaFFAA’s endorsement of this initiative.
“We must
take a stand as a community and use our influence to put pressure on these
giant companies to make the vaccine affordable not only for children in the
Philippines but for all children all over the world,” Rivera said. “The
petition campaign ends next Tuesday so we’re calling on everyone to tell their
family, friends and co-workers to sign now. It is critical that we make our
voices heard.”
The link
to the petition is www.nextdaybetter.com/afairshot. The goal is to
collect 300,000 signatures by April 26. The petitions will be delivered to the
offices of Pfizer and GSK the following day.
Rivera, who is President of the Philippine Medical Society of Greater Philadelphia (PMSGP), posted the online link to the petition a week ago, which was in turn shared by NaFFAA members nationwide.
Rivera, who is President of the Philippine Medical Society of Greater Philadelphia (PMSGP), posted the online link to the petition a week ago, which was in turn shared by NaFFAA members nationwide.
Among
those responding is Dr. Nanette Bernabe Quion of Arlington, Virginia, a
pediatrician who is trained in public health. “This vaccine will save millions
of lives,” she wrote in a Facebook post. “This vaccine has been proven to be
safe and efficacious. The expensive cost of drug development should not be
borne by poor and developing countries. It is very unfortunate that the
Philippine DOH has not included the pneumococcal vaccine in its Expanded Program
of immunization when it is a proven and cost effective vaccine. We should have
spent on this vaccine, which has a better safety profile, instead of the
haphazard implementation of the dengue vaccine.”
In
explaining NDB’s collaboration with Doctors Without Borders, Letada says that
they “recognize that the Filipino diaspora is a source of world-class
healthcare professionals (nurses, doctors, physical therapy) and public health
community organizers. Without Filipino healthcare professionals, the global healthcare
system would implode — that’s how influential and critical we are as a
community.
“Doctors
Without Borders and NextDayBetter believe that the Filipino diaspora belong on
the decision making table when it comes to public health issues that plague our
community. This campaign is about ensuring that our community’s voice is
heard.”
No comments:
Post a Comment